Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings
Swiss health care company Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction.
Source link
- The Netherlands named the best place to retire — here’s how other countries compare
- Inflation worries the world, as Türkiye’s Finance Minister says it’s “most important priority” at Horasis Global Meeting – Argentina Reports
